GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Elicera Therapeutics AB (OSTO:ELIC) » Definitions » Beginning Cash Position

Elicera Therapeutics AB (OSTO:ELIC) Beginning Cash Position : kr30.63 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Elicera Therapeutics AB Beginning Cash Position?

Elicera Therapeutics AB's Beginning Cash Position for the quarter that ended in Dec. 2024 was kr30.63 Mil.

Elicera Therapeutics AB's quarterly Beginning Cash Position declined from Jun. 2024 (kr40.71 Mil) to Sep. 2024 (kr32.86 Mil) and declined from Sep. 2024 (kr32.86 Mil) to Dec. 2024 (kr30.63 Mil).

Elicera Therapeutics AB's annual Beginning Cash Position declined from Dec. 2022 (kr52.39 Mil) to Dec. 2023 (kr43.82 Mil) and declined from Dec. 2023 (kr43.82 Mil) to Dec. 2024 (kr29.38 Mil).

Elicera Therapeutics AB Beginning Cash Position Historical Data

The historical data trend for Elicera Therapeutics AB's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elicera Therapeutics AB Beginning Cash Position Chart

Elicera Therapeutics AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beginning Cash Position
Get a 7-Day Free Trial 0.03 11.57 52.39 43.82 29.38

Elicera Therapeutics AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.88 29.38 40.71 32.86 30.63

Elicera Therapeutics AB Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Elicera Therapeutics AB Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Elicera Therapeutics AB's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Elicera Therapeutics AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Elicera Therapeutics AB (OSTO:ELIC) » Definitions » Beginning Cash Position
Comparable Companies
OSTO:ALZCUR OSTO:ANNX OSTO:MVIR OSTO:CLBIO XSAT:CURAS OSTO:ALZ OSTO:KDEV OSTO:IMMU NGM:GTAB B OSTO:KAN VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Massans gata 10, World Trade Center Goteborg, 7th Floor, Goteborg, SWE, SE-412 51
Website
https://www.elicera.com
Elicera Therapeutics AB is a Sweden-based clinical-stage immuno-oncology company developing cell and gene therapies for immune-based cancer treatments. The company's product portfolio consists of four drug candidates, two in the field of oncolytic viruses (ELC-100 and ELC-201) and two in the field of CAR T-cell treatments (ELC-301 and ELC-401), in addition to a universal CAR T-cell technology platform, iTANK (ELC-001), compatible with any CAR T-cell therapy for a multi-targeted attack on solid tumors.

Elicera Therapeutics AB Headlines

No Headlines